HeraMED Receives positive interim results in HeraCARE paid pilot program
- Pregnancy technology company HeraMED (HMD) receives interim results from its paid pilot agreement with Obstetrix Medical Group
- The companies signed an agreement in mid-May to evaluate the functionality and suitability of the HeraCARE platform
- The interim results have been very positive with an 89 per cent overall positive patient adherence rate achieved
- Furthermore, 100 percent of the professional care team indicated HeraCARE is safe and effective
- The second pilot site will be the Obstetrix practice in Atlanta, Georgia, with shipment of the hardware expected on September 15
- Shares in HeraME’D are up 11.4 per cent on the market and are trading at 19.5 cents at 12:30 pm AEST
